
Summary:
In this podcast, you will hear Michelle Crouthamel discussing how AbbVie has implemented digital health technologies to digitize measurements that can improve existing endpoints, uncover new endpoints and reduce the burden on patients by eliminating the need to travel to sleep labs. This took place with Antoniu Fantana, PhD, Eli Lilly, at the 2022 Mobile Tech in Clinical Trials conference.
To learn more about the Mobile Tech in Clinical Trials conference, please visit mobileinclinicaltrials.com
SpeakersRelated Podcasts
View All
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development

Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles

Simplicity in Technology Delivery for Clinical Trials
